Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers - Report - MDSpire

Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers

  • By

  • Anhui Liu

  • Hanbin Chen

  • Qingxiang Liu

  • Mahmoud Al-Azab

  • Fahmi Shaher

  • Jiang Li

  • Tao Liu

  • Min Yang

  • June 17, 2026

  • 0 min

Share

Clinical Report: Cardiovascular Effects of Long COVID: Immune Dysregulation and Inflammation

Overview

{'add': 'Include examples of cardiovascular complications such as ischemic heart disease and arrhythmias.'}

Background

{'add': 'Incorporate statistics on Long COVID prevalence from various studies.'}

Data Highlights

{'modify': 'State that the absence of numerical data is a limitation of the report.'}

Key Findings

{'modify': 'Emphasize the variability in immune dysregulation among Long COVID patients.'}

Clinical Implications

{'add': 'Include specific monitoring strategies for cardiovascular symptoms.'}

Conclusion

{'modify': 'Highlight the need for further research into Long COVID mechanisms.'}

Related Resources & Content

  1. Frontiers in Cardiovascular Medicine, 2026 -- Unraveling the cardiovascular burden of long COVID: symptom profiles, underlying mechanisms, and clinical management insights
  2. European Journal of Preventive Cardiology, 2026 -- Cardiovascular disease as part of Long COVID: a systematic review
  3. conexiant, 2026 -- Long COVID May Raise Cardiovascular Risk
  4. European Journal of Preventive Cardiology, 2026 -- Behind the shadows: bringing the cardiovascular secrets of long COVID into light
  5. Long COVID Clinical Guidance | Long COVID | CDC, 2026
  6. Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis - PMC
  7. Long COVID Clinical Guidance | Long COVID | CDC
  8. Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis - PMC
  9. Effectiveness of Colchicine for the Treatment of Long COVID

Original Source(s)

Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers

  • by Anhui Liu, Hanbin Chen, Qingxiang Liu, Mahmoud Al-Azab, Fahmi Shaher, Jiang Li, Tao Liu, Min Yang

  • June 17, 2026

Related Content

Differential effects of transcatheter edge-to-edge repair on forward stroke volume in atrial and ventricular secondary mitral regurgitation

Long-term efficacy and renal safety of SGLT2 inhibitors in patients with heart failure and advanced chronic kidney disease (stage 4): a propensity score-matched retrospective cohort study

Implantation of cardiac resynchronization therapy defibrillator with left bundle branch pacing in a patient with mirror-image dextrocardia: a case report